U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07636161) titled 'PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)' on June 03.
Brief Summary: The purpose of this research study is to look at whether Eroxon(R) gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Type 2 Diabetes (T2DM)
Intervention:
DEVICE: Eroxon(R)
Participants will receive a 12-week supply of Eroxon(R) and will be instructed to apply the gel prior to each sexual encounter as directed at enrollment.
DRUG: tadalafil
Tadalafil is ad...